JP2023524039A5 - - Google Patents
Info
- Publication number
- JP2023524039A5 JP2023524039A5 JP2022566066A JP2022566066A JP2023524039A5 JP 2023524039 A5 JP2023524039 A5 JP 2023524039A5 JP 2022566066 A JP2022566066 A JP 2022566066A JP 2022566066 A JP2022566066 A JP 2022566066A JP 2023524039 A5 JP2023524039 A5 JP 2023524039A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- dose
- compound
- subject
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026087958A JP2026127654A (ja) | 2020-04-29 | 2026-05-26 | T型カルシウムチャネルモジュレーターを使用する方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063017140P | 2020-04-29 | 2020-04-29 | |
| US63/017,140 | 2020-04-29 | ||
| US202063050410P | 2020-07-10 | 2020-07-10 | |
| US63/050,410 | 2020-07-10 | ||
| US202063082946P | 2020-09-24 | 2020-09-24 | |
| US63/082,946 | 2020-09-24 | ||
| PCT/US2021/029539 WO2021222342A1 (en) | 2020-04-29 | 2021-04-28 | Methods of use of t-type calcium channel modulators |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026087958A Division JP2026127654A (ja) | 2020-04-29 | 2026-05-26 | T型カルシウムチャネルモジュレーターを使用する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524039A JP2023524039A (ja) | 2023-06-08 |
| JP2023524039A5 true JP2023524039A5 (cg-RX-API-DMAC7.html) | 2024-05-09 |
Family
ID=78373913
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566066A Pending JP2023524039A (ja) | 2020-04-29 | 2021-04-28 | T型カルシウムチャネルモジュレーターを使用する方法 |
| JP2026087958A Pending JP2026127654A (ja) | 2020-04-29 | 2026-05-26 | T型カルシウムチャネルモジュレーターを使用する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026087958A Pending JP2026127654A (ja) | 2020-04-29 | 2026-05-26 | T型カルシウムチャネルモジュレーターを使用する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12697331B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4142764A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023524039A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230018384A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115776894A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021263804A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022021946A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3177277A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL297642A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022013595A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021222342A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021007487A1 (en) | 2019-07-11 | 2021-01-14 | Praxis Precision Medicines, Inc. | Formulations of t-type calcium channel modulators and methods of use thereof |
| CA3243616A1 (en) * | 2022-02-03 | 2023-08-10 | Praxis Precision Medicines, Inc. | TREATMENT METHODS USING T-TYPE CALCIUM CHANNEL MODULATORS |
| WO2023192885A2 (en) * | 2022-03-28 | 2023-10-05 | Praxis Precision Medicines, Inc. | Methods of using oligomeric compounds to treat scn2a-related disorders |
| US20250295646A1 (en) * | 2022-05-09 | 2025-09-25 | Praxis Precision Medicines, Inc. | Methods of use of t-type calcium channel modulators |
| CN121127457A (zh) * | 2023-03-02 | 2025-12-12 | 普拉西斯精密医药公司 | T型钙通道调节剂的结晶盐和其使用方法 |
| AU2024230578A1 (en) * | 2023-03-02 | 2025-09-04 | Praxis Precision Medicines, Inc. | Crystalline salt forms of n-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide and methods of use thereof |
| WO2025059511A1 (en) | 2023-09-15 | 2025-03-20 | Praxis Precision Medicines, Inc. | Elsunersen / prax-222 for use in the treatment of scn2a-related disorders |
| WO2025188619A1 (en) * | 2024-03-04 | 2025-09-12 | Praxis Precision Medicines, Inc. | Methods of treating parkinson's disease with t-type calcium channel modulators |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8377968B2 (en) * | 2008-06-02 | 2013-02-19 | Zalicus Pharmaceuticals, Ltd. | N-piperidinyl acetamide derivatives as calcium channel blockers |
| EP3364993B1 (en) * | 2015-10-22 | 2022-11-09 | Cavion, Inc. | Methods for treating angelman syndrome |
| RU2746188C2 (ru) * | 2015-11-12 | 2021-04-08 | Афаски, Инк. | Ингибиторы ионного канала, фармацевтические составы и применение |
| HRP20220463T1 (hr) * | 2016-12-16 | 2022-05-27 | Idorsia Pharmaceuticals Ltd | Farmaceutska kombinacija koja sadrži blokator kalcijevih kanala t-tipa |
| WO2018118101A1 (en) * | 2016-12-21 | 2018-06-28 | Praxis Precision Medicines, Inc. | T-type calcium channel modulators and methods of use thereof |
| SG11202004329TA (en) * | 2017-11-10 | 2020-06-29 | Marinus Pharmaceuticals Inc | Ganaxolone for use in treating genetic epileptic disoders |
| JP7480131B2 (ja) * | 2018-10-03 | 2024-05-09 | カビオン・インコーポレイテッド | (r)-2-(4-イソプロピルフェニル)-n-(1-(5-(2,2,2-トリフルオロエトキシ)ピリジン-2-イル)エチル)アセトアミドを使用した本態性振戦の処置 |
| WO2021007487A1 (en) * | 2019-07-11 | 2021-01-14 | Praxis Precision Medicines, Inc. | Formulations of t-type calcium channel modulators and methods of use thereof |
| US20250295646A1 (en) * | 2022-05-09 | 2025-09-25 | Praxis Precision Medicines, Inc. | Methods of use of t-type calcium channel modulators |
-
2021
- 2021-04-28 CN CN202180046763.8A patent/CN115776894A/zh active Pending
- 2021-04-28 JP JP2022566066A patent/JP2023524039A/ja active Pending
- 2021-04-28 IL IL297642A patent/IL297642A/en unknown
- 2021-04-28 KR KR1020227041859A patent/KR20230018384A/ko active Pending
- 2021-04-28 AU AU2021263804A patent/AU2021263804A1/en active Pending
- 2021-04-28 BR BR112022021946A patent/BR112022021946A2/pt unknown
- 2021-04-28 WO PCT/US2021/029539 patent/WO2021222342A1/en not_active Ceased
- 2021-04-28 EP EP21795254.8A patent/EP4142764A4/en active Pending
- 2021-04-28 CA CA3177277A patent/CA3177277A1/en active Pending
- 2021-04-28 MX MX2022013595A patent/MX2022013595A/es unknown
-
2022
- 2022-10-27 US US17/975,457 patent/US12697331B2/en active Active
-
2026
- 2026-05-26 JP JP2026087958A patent/JP2026127654A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI335217B (en) | Pharmaceutical formulations of modafinil | |
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| CN101600438A (zh) | 疼痛疾病治疗剂 | |
| JP2026035701A5 (cg-RX-API-DMAC7.html) | ||
| EP3678643B1 (en) | Sublingual epinephrine tablets | |
| JP2018507243A5 (cg-RX-API-DMAC7.html) | ||
| JP2023535744A5 (cg-RX-API-DMAC7.html) | ||
| US20220096475A1 (en) | Method for treating sarcoidosis-associated pulmonary hypertension | |
| JP2021152060A (ja) | アカンプロセートおよびd−サイクロセリンを使用する組み合わせ療法 | |
| JP2022521233A5 (cg-RX-API-DMAC7.html) | ||
| US20230233496A1 (en) | Levodopa fractionated dose composition and use | |
| US11304923B2 (en) | Use of a benzoate containing composition to treat glycine encephalopathy | |
| US5985933A (en) | Methods for treating central and peripheral nerve pain | |
| CN109172550B (zh) | 一种复合麻醉药物 | |
| Grøn | Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease | |
| US8785469B2 (en) | Method of treating atherogenic dyslipidemia | |
| JP2022506019A (ja) | 高用量の放出調節フペルジン製剤の使用 | |
| JP2024059812A5 (ja) | 鏡像異性体的に濃縮された、または純粋なブプロピオンの組成物 | |
| JP2021530568A5 (cg-RX-API-DMAC7.html) | ||
| JP2021509671A5 (cg-RX-API-DMAC7.html) | ||
| JP2024502466A5 (cg-RX-API-DMAC7.html) | ||
| US12161612B2 (en) | Methods and compositions for reducing symptoms of Parkinson's disease | |
| JP2025505578A5 (cg-RX-API-DMAC7.html) | ||
| JP2023533472A5 (cg-RX-API-DMAC7.html) |